![]() |
市場調查報告書
商品編碼
1403473
到 2030 年藥品膠囊檢查賭注市場預測:按自動化程度、產能、整合程度、技術、應用、最終用戶和地區進行的全球分析Pharmaceutical Capsule Checkweigher Market Forecasts to 2030 - Global Analysis By Automation Level, Capacity, Integration Level, Technology, Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球藥品膠囊支票投注市場在預測期內將以 6.7% 的複合年成長率成長。
專為藥用膠囊製造的檢重秤細分市場稱為藥用膠囊檢重秤市場。它專注於此類設備的生產、分銷和使用。這種精密設備對於藥品製造至關重要,可以確保每個膠囊具有相同的重量,遵守嚴格的法規並維持產品品質。校準機是藥品製造流程的關鍵要素,有助於消除給藥差異並提高患者的安全性和療效。
藥品製造商努力維持嚴格的品管要求,降低製造成本並提高效率。為了確保藥物膠囊符合規定的重量參數,Checkwager 在稱重過程中提供即時監控和準確性。此外,透過能夠有效率、準確地測量物體,自動檢查器可以幫助簡化生產過程、降低錯誤率並提高整體業務效率。
對於製藥公司,尤其是資金有限的小型和成長型公司來說,與檢重設備的先進技術和精度相關的高昂初期成本構成了障礙。對於希望改進品管程序的公司來說,購買、部署和整合到當前生產線的成本可能是一個障礙。為了進一步增加整體財務負擔,投資不僅限於採購,還包括驗證、維護和培訓成本。
需要提高生產能力來滿足世界對藥品日益成長的需求,而有效且可靠的品管程序對此至關重要。在這種情況下,測試砝碼至關重要,因為它們可以確保藥物膠囊的準確重量並有助於確保藥品的整體品質。此外,隨著製藥公司提高產量以滿足醫療保健系統不斷成長的需求,CheckWager 有助於維持給藥準確性並避免給藥和給藥問題,使用極為重要。
詐欺的存取和有害活動可能會針對零售稱重設備產生的資料。資料可以包括有關藥物配方和製造程序的重要資訊。確保這些資訊的隱私性、準確性和可近性對於防止智慧財產權盜竊、偽造和藥品生產中斷至關重要。為了保護敏感資料,秤製造商和使用者必須實施強力的網路安全措施,包括加密、存取限制和頻繁的安全審核。
製藥業務受到生產放緩、全球供應鏈中斷以及必需品優先排序的影響,所有這些都影響了零售稱重設備的需求。儘管為應對這場流行病,藥品生產急劇增加,但對基本治療的關注已經改變了生產重點。為了應對不確定性,一些製造商已推遲或重新考慮購買新機械,例如稱重機。封鎖和旅行限制也使得安裝和維護檢重設備變得困難。
預計自動檢查器市場將在整個預測期內快速成長。這是因為它能夠在藥物膠囊製造過程中提高營運效率,降低人事費用,並提供準確、快速、即時的重量測量。此外,自動秤提供了一種優雅的方式,可以將品管順利地整合到對準確性和精密度至關重要的製藥操作中的大批量生產中。
獨立檢查器預計將在預測期內快速成長,因為它們提供不需要重大修改並且可以輕鬆整合到當前製藥生產線的獨立解決方案。此外,尋求有效的品管解決方案而無需重組整個供應鏈的製藥公司可能會發現這種彈性很有吸引力。由獨立稱重機提供藥物膠囊的精確重量測量,確保符合法律要求並維持產品品質。
在亞太地區,稱重機的使用顯著增加,該地區的製藥商優先考慮提高生產效率、確保法律規章規性並維持最高的產品品質標準。該地區佔據了最大的市場佔有率。此外,自動檢重技術提供的功能符合人們對藥物配方精確度和精確度的日益重視。由於監管機構強調準確的給藥測量和遵守國際品質標準,檢重秤已成為藥品生產業務的重要組成部分。
北美地區正在經歷良好的成長。嚴格的法規環境,例如美國食品藥物食品藥物管理局(FDA) 實施的監管環境,需要嚴格的品管程序,使得支票在藥品製造業務中變得越來越重要。此外,由於關注患者安全和準確估計給藥的需要,北美製藥公司擴大使用秤來維持監管合規性。
2023 年 7 月 Thermo Fisher Scientific, Inc.(以下簡稱「Thermo Fisher」)是科學服務領域的全球領導者,今天宣布,該公司是核准治療方法和治療方法。簽署最終協議收購供應商CorEvitas, LLC。
13.1 OCS檢重秤有限公司
13.2 賽默飛世爾科技公司
13.3 安立公司
13.4 多佛公司
13.5上海比隆儀器有限公司
13.6 梅特勒-托利多國際公司
13.7 Wipotec-OCS 有限公司
13.8 碧彩有限公司
13.9 世宗製藥科技
According to Stratistics MRC, the Global Pharmaceutical Capsule Checkweigher Market is growing at a CAGR of 6.7% during the forecast period. The market segment for check-weighing equipment made especially for pharmaceutical capsules is known as the Pharmaceutical Capsule Checkweigher Market. It is concentrated on the production, distribution, and use of this type of equipment. By ensuring that each capsule weighs identically, ensuring that strict regulations are adhered to, and preserving product quality, this precision equipment is essential to the manufacturing of pharmaceuticals. Checkweighers, a crucial component of the pharmaceutical production process, help to eliminate dosage discrepancies, improving patient safety and efficacy.
Manufacturers of pharmaceuticals strive intensively to maintain strict quality control requirements, lower production costs, and increase efficiency. To ensure that pharmaceutical capsules satisfy specified weight parameters, checkweighers provide real-time monitoring and precision in the weighing process, which is crucial to attaining these objectives. Additionally, because they can measure objects efficiently and accurately, automated check weighers help to streamline production processes, reduce mistake rates, and improve overall operational efficiency.
Pharmaceutical producers have a hurdle because of the high upfront expenses associated with check weighing equipment's sophisticated technology and precision, particularly for smaller or growing businesses with limited funding. The cost of purchasing, placing in position, and integrating checkweighers into current production lines can be a barrier for businesses seeking to improve their quality control procedures. To further increase the entire financial commitment, the investment expands beyond acquisition to cover costs for validation, maintenance, and training.
Increased manufacturing capacity is required to meet the growing global demand for medicines, which emphasizes the importance of effective and dependable quality control procedures. In this context, check weighers are essential as they ensure the exact weight of pharmaceutical capsules, which helps to ensure the total quality assurance of drugs. Additionally, the use of check weighers is crucial to preserving dosage accuracy and avoiding problems with under or overdosing as pharmaceutical businesses increase their production volumes to meet the growing demands of the healthcare system.
Unauthorized access or harmful activity may target the data produced by checkweighing equipment, which may contain critical information regarding pharmaceutical formulations and production procedures. It is crucial to ensure the privacy, accuracy, and accessibility of this information in order to prevent intellectual property theft, counterfeiting, and interruptions in the production of pharmaceuticals. To protect sensitive data, checkweigher manufacturers and users must set strong cybersecurity measures in place, such as encryption, access limits, and frequent security audits.
The pharmaceutical business was impacted by production slowdowns, global supply chain disruptions, and the prioritization of necessities, which all had an impact on the demand for checkweighing equipment. Despite the fact that pharmaceutical manufacturing increased dramatically in response to the epidemic, priorities in production shifted as a result of the primary focus on essential treatments. To manage uncertainty, a few manufacturers experienced delays or reconsidered their purchases of new machinery, such as checkweighers. Lockdowns and travel restrictions also made it difficult to install and maintain checkweighing equipment.
The market for automatic checkweighers is anticipated to grow at a rapid pace throughout the projected period because of its capacity to improve operational effectiveness, reduce labor costs, and offer accurate, fast, and real-time weight measurements in the pharmaceutical capsule production process. Additionally, automatic checkweighers provide a sophisticated way to smoothly integrate quality control into high-volume manufacturing in the pharmaceutical business, where accuracy and precision are critical.
Because it provides a stand-alone solution that can be readily integrated into current pharmaceutical production lines without requiring significant changes, the Standalone Checkweighers segment is anticipated to grow at a rapid pace throughout the projected period. Moreover, pharmaceutical businesses looking for effective quality control solutions without having to reorganize their entire supply chain may find this flexibility appealing. Accurate weight measurements for pharmaceutical capsules are provided by standalone checkweighers, ensuring adherence to legal requirements and preserving product quality.
The usage of checkweighers is significantly increasing in the Asia-Pacific area, where pharmaceutical manufacturers prioritize improving production efficiency, guaranteeing regulatory compliance, and maintaining the highest standards of product quality. This region held the largest share of the market. Furthermore, the capabilities provided by check weighing technology are in line with the growing emphasis on accuracy and precision in dosage formulations. Checkweighers are an essential part of pharmaceutical manufacturing operations because regulatory bodies emphasize the importance of precise dosage measurements and compliance with international quality standards.
North America region is experiencing lucrative growth. Strict regulatory environments, such as those imposed by the Food and Drug Administration (FDA) in the United States, require stringent quality control procedures, which increases the significance of checkweighers in pharmaceutical production operations. Moreover, checkweighing equipment is becoming more widely used by pharmaceutical businesses in North America to maintain regulatory compliance, with a focus on patient safety and the necessity for precise dosage estimates.
Some of the key players in Pharmaceutical Capsule Checkweigher market include: OCS Checkweighers GmbH, Thermo Fisher Scientific Inc., Anritsu Corporation, Dover Corporation, Shanghai Bilon Instrument Co., Ltd, Mettler-Toledo International Inc., Wipotec-OCS GmbH, Bizerba GmbH & Co. KG and Sejong Pharmatech.
In July 2023, Thermo Fisher Scientific Inc ("Thermo Fisher"), the world leader in serving science, today announced it has entered into a definitive agreement to acquire CorEvitas, LLC, a leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies.
13.1 OCS Checkweighers GmbH
13.2 Thermo Fisher Scientific Inc.
13.3 Anritsu Corporation
13.4 Dover Corporation
13.5 Shanghai Bilon Instrument Co., Ltd
13.6 Mettler-Toledo International Inc.
13.7 Wipotec-OCS GmbH
13.8 Bizerba GmbH & Co. KG
13.9 Sejong Pharmatech